- Positron emission tomography
Positron emission tomography (PET) is a
nuclear medicineimaging technique which produces a three-dimensional image or map of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide(tracer), which is introduced into the body on a biologically active molecule. Images of tracer concentration in 3-dimensional space within the body are then reconstructed by computer analysis. In modern scanners, this reconstruction is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.
If the biologically active molecule chosen for PET is
FDG, an analogue of glucose, the concentrations of tracer imaged then give tissue metabolic activity, in terms of regional glucose uptake. Although use of this tracer results in the most common type of PET scan, other tracer molecules are used in PET to image the tissue concentration of many other types of molecules of interest.
To conduct the scan, a short-lived radioactive tracer
isotope, is injected into the living subject (usually into bloodcirculation). The tracer is chemically incorporated into a biologically active molecule, and eventually decays, emitting a positron. There is a waiting period while the active molecule becomes concentrated in tissues of interest; then the research subject or patient is placed in the imaging scanner. The molecule most commonly used for this purpose is fluorodeoxyglucose(FDG), a sugar, for which the waiting period is typically an hour.As the radioisotope undergoes positron emissiondecay (also known as positive beta decay), it emits a positron, the antimattercounterpart of an electron. After travelling up to a few millimetersthe positron encounters and annihilates with an electron, producing a pair of annihilation (gamma) photons moving in opposite directions. These are detected when they reach a scintillatormaterial in the scanning device, creating a burst of light which is detected by photomultipliertubes or silicon avalanche photodiodes (Si APD). The technique depends on simultaneous or coincident detection of the pair of photons; photons which do not arrive in pairs (i.e. within a timing window of few nanoseconds) are ignored.
Localization of the positron annihilation event
The most significant fraction of electron-positron decays result in two 511 keV gamma photons being emitted at almost 180 degrees to each other; hence it is possible to localize their source along a straight line of coincidence (also called formally the line of response or LOR). In practice the LOR has a finite width as the emitted photons are not exactly 180 degrees apart. If the recovery time of detectors is in the picosecond range rather than the 10's of nanosecond range, it is possible to localize the event to a segment of a cord, whose length is determined by the detector timing resolution. As the timing resolution improves, the signal-to-noise ratio (SNR) of the image will improve, requiring less events to achieve the same image quality. This technology is not yet common, but it is available on some new systems [http://www.uphs.upenn.edu/news/News_Releases/jun06/PETCTITC.htm] .
Image reconstruction using coincidence statistics
More commonly, a technique much like the reconstruction of
computed tomography(CT) and single photon emission computed tomography(SPECT) data is used, although the data setcollected in PET is much poorer than CT, so reconstruction techniques are more difficult (see Image reconstruction of PET).
Using statistics collected from tens-of-thousands of coincidence events, a set of simultaneous equations for the total activity of each parcel of tissue along many LORs can be solved by a number of techniques, and thus a map of radioactivities as a function of location for parcels or bits of tissue (also called
voxels), may be constructed and plotted. The resulting map shows the tissues in which the molecular probe has become concentrated, and can be interpreted by a nuclear medicine physician or radiologistin the context of the patient's diagnosis and treatment plan.
Combination of PET with CT and MRI
PET scans are increasingly read alongside CT or
magnetic resonance imaging(MRI) scans, the combination ("co-registration") giving both anatomic and metabolic information (i.e., what the structure is, and what it is doing biochemically). Because PET imaging is most useful in combination with anatomical imaging, such as CT, modern PET scanners are now available with integrated high-end multi-detector-row CT scanners. Because the two scans can be performed in immediate sequence during the same session, with the patient not changing position between the two types of scans, the two sets of images are more-precisely registered, so that areas of abnormality on the PET imaging can be more perfectly correlated with anatomy on the CT images. This is very useful in showing detailed views of moving organs or structures with higher amounts of anatomical variation, such as are more likely to occur outside the brain.
Radionuclides used in PET scanning are typically isotopes with short half lives such as carbon-11(~20 min), nitrogen-13(~10 min), oxygen-15(~2 min), and fluorine-18(~110 min). These radionuclides are incorporated either into compounds normally used by the body such as glucose(or glucose analogues), wateror ammonia, or into molecules that bind to receptors or other sites of drug action. Such labelled compounds are known as radiotracers. It is important to recognize that PET technology can be used to trace the biologic pathway of any compound in living humans (and many other species as well), provided it can be radiolabeled with a PET isotope. Thus the specific processes that can be probed with PET are virtually limitless, and radiotracers for new target molecules and processes are being synthesized all the time; as of this writing there are already dozens in clinical use and hundreds applied in research. Due to the short half lives of most radioisotopes, the radiotracers must be produced using a cyclotronand radiochemistry laboratory that are in close proximity to the PET imaging facility. The half life of fluorine-18is long enough such that fluorine-18labeled radiotracers can be manufactured commercially at an offsite location.
The minimization of radiation dose to the subject is an attractive feature of the use of short-lived radionuclides. Besides its established role as a diagnostic technique, PET has an expanding role as a method to assess the response to therapy, in particular, cancer therapy, [cite journal | author=Young H, Baum R, Cremerius U, "et al." | title=Measurement of clinical and subclinical tumour response using [18F] -fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations.| journal=European Journal of Cancer| volume=35 | issue=13 | year=1999| pages=1773–1782 | doi = 10.1016/S0959-8049(99)00229-4 ] where the risk to the patient from lack of knowledge about disease progress is much greater than the risk from the test radiation.
Limitations to the widespread use of PET arise from the high costs of
cyclotronsneeded to produce the short-lived radionuclides for PET scanning and the need for specially adapted on-site chemical synthesis apparatus to produce the radiopharmaceuticals. Few hospitals and universities are capable of maintaining such systems, and most clinical PET is supported by third-party suppliers of radiotracers which can supply many sites simultaneously. This limitation restricts clinical PET primarily to the use of tracers labelled with F-18, which has a half life of 110 minutes and can be transported a reasonable distance before use, or to rubidium-82, which can be created in a portable generator and is used for myocardial perfusionstudies. Nevertheless, in recent years a few on-site cyclotrons with integrated shielding and hot labs have begun to accompany PET units to remote hospitals. The presence of the small on-site cyclotron promises to expand in the future as the cyclotrons shrink in response to the high cost of isotope transportation to remote PET machines [ [http://www.medicalimagingmag.com/issues/articles/2003-07_05.asp Technology | July 2003: Trends in MRI | Medical Imaging ] ]
Because the half-life of F-18 is about two hours, the prepared dose of a radiopharmaceutical bearing this radionuclide will undergo multiple half-lives of decay during the working day. This necessitates frequent recalibration of the remaining dose (determination of activity per unit volume) and careful planning with respect to patient scheduling.
The raw data collected by a PET scanner are a list of 'coincidence events' representing near-simultaneous detection of annihilation photons by a pair of detectors. Each coincidence event represents a line in space connecting the two detectors along which the positron emission occurred.
Coincidence events can be grouped into projections images, called
sinograms. The sinograms are sorted by the angle of each view and tilt, the latter in 3D case images. The sinogram images are analogous to the projections captured by computed tomography(CT) scanners, and can be reconstructed in a similar way. However, the statistics of the data is much worse than those obtained through transmission tomography. A normal PET data set has millions of counts for the whole acquisition, while the CT can reach a few billion counts. As such, PET data suffer from scatter and random events much more dramatically than CT data does.
In practice, considerable pre-processing of the data is required - correction for random coincidences, estimation and subtraction of scattered photons, detector dead-time correction (after the detection of a photon, the detector must "cool down" again) and detector-sensitivity correction (for both inherent detector sensitivity and changes in sensitivity due to angle of incidence).
Filtered back projection(FBP) has been frequently used to reconstruct images from the projections. This algorithm has the advantage of being simple while having a low requirement for computing resources. However, shot noisein the raw data is prominent in the reconstructed images and areas of high tracer uptake tend to form streaks across the image.
expectation-maximization algorithms are now the preferred method of reconstruction. The advantage is a better noise profile and resistance to the streak artifacts common with FBP, but the disadvantage is higher computer resource requirements.
Attenuation correction: As different LORs must traverse different thicknesses of tissue, the
photons are attenuated differentially. The result is that structures deep in the body are reconstructed as having falsely low tracer uptake. Contemporary scanners can estimate attenuation using integrated x-rayCT equipment, however earlier equipment offered a crude form of CT using a gamma ray( positronemitting) source and the PET detectors.
While attenuation corrected images are generally more faithful representations, the correction process is itself susceptible to significant artifacts. As a result, both corrected and uncorrected images are always reconstructed and read together.
2D/3D reconstruction: Early PET scanners had only a single ring of detectors, hence the acquisition of data and subsequent reconstruction was restricted to a single transverse plane. More modern scanners now include multiple rings, essentially forming a cylinder of detectors.
There are two approaches to reconstructing data from such a scanner: 1) treat each ring as a separate entity, so that only coincidences within a ring are detected, the image from each ring can then be reconstructed individually (2D reconstruction), or 2) allow coincidences to be detected between rings as well as within rings, then reconstruct the entire volume together (3D).
3D techniques have better sensitivity (because more coincidences are detected and used) and therefore less noise, but are more sensitive to the effects of scatter and random coincidences, as well as requiring correspondingly greater computer resources. The advent of sub-nanosecond timing resolution detectors affords better random coincidence rejection, thus favoring 3D image reconstruction.
The concept of emission and transmission tomography was introduced by
David Kuhland Roy Edwards in the late 1950s. Their work later led to the design and construction of several tomographic instruments at the University of Pennsylvania. Tomographic imaging techniques were further developed by Michel Ter-Pogossian, Michael E. Phelpsand others at the Washington University School of Medicine. [cite journal
title=A positron-emission transaxial tomograph for nuclear imaging (PET)
coauthors=M.E. Phelps, E.J. Hoffman
volume = 114
issue = 1
pages = 89-98
url=http://www.osti.gov/energycitations/product.biblio.jsp?osti_id=4251398] [cite journal
title=Application of annihilation coincidence detection to transaxial reconstruction tomography
coauthors=E.J. Hoffman, N.A. Mullani, M.M. Ter-Pogossian
Journal of Nuclear Medicine
volume = 16
issue = 3
pages = 210-224
Work by Gordon Brownell, Charles Burnham and their associates at the
Massachusetts General Hospitalbeginning in the 1950s contributed significantly to the development of PET technology and included the first demonstration of annihilation radiation for medical imaging [cite journal
title=Localization of brain tumors with positron emitters
volume = 11
pages = 40-45
year=1953] . Their innovations, including the use of light pipes, and volumetric analysis have been important in the deployment of PET imaging.
In the 1970s, Tatsuo Ido at the Brookhaven National Laboratory was the first to describe the synthesis of 18F-
FDG, the most commonly used PET scanning isotope carrier. The compound was first administered to two normal human volunteers by Abass Alaviin August 1976 at the University of Pennsylvania. Brain images obtained with an ordinary (non-PET) nuclear scanner demonstrated the concentration of FDG in that organ. Later, the substance was used in dedicated positron tomographic scanners, to yield the modern procedure.
Maximum intensity projection(MIP) of a typical F-18 FDG wholebody PET acquisition] PET is both a medical and research tool. It is used heavily in clinical oncology(medical imaging of tumors and the search for metastases), and for clinical diagnosis of certain diffuse brain diseases such as those causing various types of dementias. PET is also an important research tool to map normal human brain and heart function.
PET is also used in pre-clinical studies using animals, where it allows repeated investigations into the same subjects. This is particularly valuable in cancer research, as it results in an increase in the statistical quality of the data (subjects can act as their own control) and substantially reduces the numbers of animals required for a given study.
Alternative methods of scanning include
x-ray computed tomography(CT), magnetic resonance imaging(MRI) and functional magnetic resonance imaging(fMRI), ultrasoundand single photon emission computed tomography(SPECT).
While some imaging scans such as CT and
MRIisolate organic anatomic changes in the body, PET and SPECT are capable of detecting areas of molecular biologydetail (even prior to anatomic change). PET scanning does this using radiolabelled molecular probes that have different rates of uptake depending on the type and function of tissue involved. Changing of regional blood flow in various anatomic structures (as a measure of the injected positron emitter) can be visualized and relatively quantified with a PET scan.
PET imaging is best performed using a dedicated PET scanner. However, it is possible to acquire PET images using a conventional dual-head
gamma camerafitted with a coincidence detector. The quality of gamma-camera PET is considerably lower, and acquisition is slower. However, for institutions with low demand for PET, this may allow on-site imaging, instead of referring patients to another center, or relying on a visit by a mobile scanner.
PET is a valuable technique for some diseases and disorders, because it is possible to target the radio-chemicals used for particular bodily functions.
Oncology: PET scanning with the tracer fluorine-18(F-18) fluorodeoxyglucose(FDG), called FDG-PET, is widely used in clinical oncology. This tracer is a glucoseanalog that is taken up by glucose-using cells and phosphorylated by hexokinase(whose mitochondrialform is greatly elevated in rapidly-growing malignanttumours). A typical dose of FDG used in an oncological scan is 200-400 MBq for an adult human. Because the oxygenatom which is replaced by F-18 to generate FDG is required for the next step in glucose metabolismin all cells, no further reactions occur in FDG. Furthermore, most tissues (with the notable exception of liver and kidneys) cannot remove the phosphateadded by hexokinase. This means that FDG is trapped in any cell which takes it up, until it decays, since phosphorylated sugars, due to their ionic charge, cannot exit from the cell. This results in intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and most cancers. As a result, FDG-PET can be used for diagnosis, staging, and monitoring treatment of cancers, particularly in Hodgkin's disease, non Hodgkin's lymphoma, and lung cancer. Many other types of solid tumors will be found to be very highly labeled on a case-by-case basis-- a fact which becomes especially useful in searching for tumor metastasis, or for recurrence after a known highly-active primary tumor is removed. Because individual PET scans are more expensive than "conventional" imaging with computed tomography(CT) and magnetic resonance imaging(MRI), expansion of FDG-PET in cost-constrained health services will depend on proper health technology assessment; this problem is a difficult one because structural and functional imaging often cannot be directly compared, as they provide different information. Oncology scans using FDG make up over 90% of all PET scans in current practice.
# plaques in the brains of Alzheimer's patients. This technology could assist clinicians in making a positive clinical diagnosis of AD pre-mortem and aid in the development of novel anti-amyloid therapies.
Cardiology, atherosclerosisand vascular disease study: In clinical cardiology, FDG-PET can identify so-called "hibernating myocardium", but its cost-effectivenessin this role versus SPECT is unclear. Recently, a role has been suggested for FDG-PET imaging of atherosclerosisto detect patients at risk of stroke[http://circ.ahajournals.org/cgi/content/abstract/105/23/2708] .
Neuropsychology/ Cognitive neuroscience: To examine links between specific psychological processes or disorders and brain activity.
Psychiatry: Numerous compounds that bind selectively to neuroreceptors of interest in biological psychiatry have been radiolabeled with C-11 or F-18. Radioligands that bind to dopamine receptors (D1,D2, reuptake transporter), serotonin receptors (5HT1A, 5HT2A, reuptake transporter) opioid receptors (mu) and other sites have been used successfully in studies with human subjects. Studies have been performed examining the state of these receptors in patients compared to healthy controls in schizophrenia, substance abuse, mood disorders and other psychiatric conditions.
Pharmacology: In pre-clinical trials, it is possible to radiolabel a new drug and inject it into animals. The uptake of the drug, the tissues in which it concentrates, and its eventual elimination, can be monitored far more quickly and cost effectively than the older technique of killing and dissecting the animals to discover the same information. A miniature PET tomograph has been constructed that is small enough for a fully conscious and mobile rat to wear on its head while walking around [http://www.chemistry.bnl.gov/ratcap/gallery.html] . This RatCAP (Rat Conscious Animal PET) allows animals to be scanned without the confounding effects of anesthesia. PET scanners for rats and non-human primates are marketed for this purpose. The technique is still generally too expensive for the veterinary medicine market, however, so very few pet PET scans are done. Drug occupancy at the purported site of action can also be inferred indirectly by competition studies between unlabeled drug and radiolabeled compounds known apriori to bind with specificity to the site.
PET scanning is non-invasive, but it does involve exposure to
ionizing radiation. The total dose of radiation is small, however, usually around 7 mSv. This can be compared to 2.2 mSv average annual background radiationin the UK, 0.02 mSv for a chest x-ray, up to 8 mSv for a CT scan of the chest, 2-6 mSv per annum for aircrew (data from UK National Radiological Protection Board). Patients with small children may be advised to limit proximity to them for several hours following the completion of the test.
Diffuse optical imaging
Hot cell(Equipment used to produce the radiopharmaceuticals used in PET)
* [http://rad.usuhs.edu/medpix/master.php3?mode=image_finder&action=search&srchstr=&srch_type=all&labels=&details=2&no_filter=2&plane_id=&capt_id=-4&filter_m=modality&filter_o=&acr_pre=&filter_p=&acr_post=#top PET Images] Search MedPix(r)
* [http://www.natureprotocols.com/2006/12/21/seeing_is_believing_in_vivo_fu_1.php Seeing is believing: In vivo functional real-time imaging of transplanted islets using positron emission tomography (PET)(a protocol)]
* [http://nuccast.com The nuclear medicine and molecular medicine podcast] - Podcast
Wikimedia Foundation. 2010.